PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: Primary and Secondary endpoints met in MPS I Trial, page-23

  1. 152 Posts.
    lightbulb Created with Sketch. 134
    https://hotcopper.com.au/data/attachments/5332/5332357-d025f3cb8d9ca90e071a8a707f1a1fb1.jpg
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.